Hong Kong Pharmaceuticals Stock News

How Sinohope Technology Holdings Framed Its FY 2025 Numbers Sinohope Technology Holdings (SEHK:1611) has put out its FY 2025 scorecard with second half revenue of HK$5.2b and basic EPS of HK$0.005, while the first half of the year saw revenue of HK$3.5b and an EPS loss of HK$0.026. Over the prior period in 2024, the company reported second half revenue of HK$913.8m with an EPS loss of HK$0.098, so the latest top line and per share results sit against a very different backdrop. For investors,...

Tencent Holdings (SEHK:700) is using the Lunar New Year period to promote its Yuanbao AI chatbot app with a digital red envelope campaign. The move comes as Alibaba and other Chinese tech firms increase promotional spending to attract AI users. The campaign coincides with investor concerns about possible changes to value added tax treatment for internet companies in China. Tencent, a major internet company in China with businesses spanning social media, gaming and fintech, is now putting...

Lenovo announced at ISE 2026 a new series of AI-powered full-room meeting solutions built on ThinkSmart Core Gen 2 and Huddly’s intelligent audio-video devices, offering unified management and consistent Microsoft Teams Rooms and Zoom Room experiences across different room sizes. By tightly integrating AI-optimized compute, modular multi-camera systems, and centralized device management, Lenovo is positioning its ThinkSmart-Huddly bundles as comprehensive infrastructure for more inclusive...

Wondering if BYD at HK$91.0 is a fair entry point or if the price is out of line with its fundamentals? This article walks through that question step by step so you can judge the value for yourself. BYD's share price is currently around HK$91.0, with a 7.6% decline over the last week and a 7.8% decline over the last month, while the 1 year return sits at 0.5% and the 3 and 5 year returns are 14.6% and 12.8% respectively. Recent headlines around BYD have focused on its role in the global...

If you are wondering whether New World Development offers value at its current price, you are not alone, especially given how sharply the stock has been moving. The share price closed at HK$10.02, with returns of 1.9% over 7 days, 35.6% over 30 days, 35.6% year to date, and 142.6% over 1 year. The 3 year and 5 year returns sit at 49.5% and 60.1% declines. These moves have come as investors refocus on Hong Kong property developers and reassess balance sheet strength and asset values across...

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...

Insilico Medicine Cayman TopCo (SEHK:3696) has secured a partnership with Qilu Pharmaceutical focused on cardiometabolic disease drug candidates. The company received FDA IND clearance for a novel NLRP3 inhibitor, ISM8969, targeting Parkinson's Disease. Insilico launched its Science MMAI Gym to make its AI tools available to pharma R&D partners. A global co development agreement for ISM8969 was signed with Hygtia Therapeutics, expanding the candidate's reach. For investors tracking AI...

In the last year, many Mao Geping Cosmetics Co., Ltd. ( HKG:1318 ) insiders sold a substantial stake in the company...

Key Insights Shanghai Chicmax Cosmetic's estimated fair value is HK$108 based on 2 Stage Free Cash Flow to Equity...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Key Insights Insiders appear to have a vested interest in Johnson Electric Holdings' growth, as seen by their sizeable...

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

Wondering whether Xiaomi’s current share price reflects its real worth, or if the market is mispricing the story you see playing out? Xiaomi closed at HK$35.06, with a 0.5% decline over the last 7 days, a 13.0% decline over the last month and year to date, and a 7.6% decline over the last year, while the 3 year return sits at 173.5% and the 5 year return at 29.1%. These moves have kept Xiaomi on many investors’ watchlists, as price swings often prompt a closer look at what is driving...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Key Insights Significant control over Yidu Tech by retail investors implies that the general public has more power to...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...

Key Insights BrainAurora Medical Technology's significant insider ownership suggests inherent interests in company's...

You may think that with a price-to-sales (or "P/S") ratio of 5.8x Shandong Boan Biotechnology Co., Ltd. ( HKG:6955 ) is...

There wouldn't be many who think Keymed Biosciences Inc.'s ( HKG:2162 ) price-to-sales (or "P/S") ratio of 16.2x is...

Looking at Global New Material International Holdings Limited's ( HKG:6616 ) insider transactions over the last year...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

In late January 2026, MTR Corporation Limited issued two senior unsecured green bonds, a 4.886% 2030 note and a 5.582% 2038 note, each worth A$1.00 billion with fixed coupons. By tapping the green bond market at scale, MTR is reinforcing its sustainable finance credentials while broadening its access to climate-focused capital. With recent share gains as a backdrop, we’ll assess how MTR’s large green bond issuance shapes its investment narrative and funding profile. We've found 13 US stocks...

It's nice to see the Central China New Life Limited ( HKG:9983 ) share price up 11% in a week. But will that repair the...

Key Insights Topsports International Holdings' significant private equity firms ownership suggests that the key...